Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-12 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psoriasis 3 D011565 ClinicalTrials
Multiple Sclerosis 2 D009103 ClinicalTrials
Crohn Disease 2 D003424 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1742995
FDA SRS 978I8M0P8X